Form 8-K - Current report:
SEC Accession No. 0000950123-10-063441
Filing Date
2010-07-02
Accepted
2010-07-02 15:23:27
Documents
3
Period of Report
2010-07-01
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K b81570e8vk.htm 8-K 22017
2 EX-3.1 b81570exv3w1.htm EX-3.1 13685
3 EX-3.2 b81570exv3w2.htm EX-3.2 100952
  Complete submission text file 0000950123-10-063441.txt   138793
Mailing Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617-349-4500
JAVELIN PHARMACEUTICALS, INC (Filer) CIK: 0000050710 (see all company filings)

EIN.: 880471759 | State of Incorp.: DE | Fiscal Year End: 0908
Type: 8-K | Act: 34 | File No.: 001-32949 | Film No.: 10935938
SIC: 2834 Pharmaceutical Preparations